Biopharma happenings, including deals and partnerships, grants, preclinical data and other news in brief: Aequus, Alzamend, Aobiome, Arthrosi, Azurrx, Cellular Engineering Technologies, Eli Lilly, Endocan Solutions, ERS Genomics, Glow Lifetech, HCW Biologics, Ico, Jaguar Health, Lixte, Nirvana Life Sciences, Revision, Satellos, Senhwa, Valeo.

Regulatory snapshots, including global drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Carrick, Edgewise, Eli Lilly, Enlivex, Galmed, Inxmed, Jupiter, Merck & Co., Oncolys, Pfizer, Sesen, Therapeutic Solutions.

Clinical updates, including trial initiations, enrollment status and data readouts and publications: Amerimmune, Axcella, Biophytis, Biosight, Brickell, Eli Lilly, Enanta, Innocare, Innovent, Moderna, Oramed, Praxis, Sagimet, Senhwa, Tikomed, Travere, Turning Point.

Regulatory snapshots, including global submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Avita Medical, Eli Lilly, Exact Sciences, Genotests, Insulet, Jenavalve, Photocure, Thermo Fisher Scientific.

Biopharma happenings, including deals and partnerships, grants, preclinical data and other news in brief: 9 Meters, Arctic, Avidity, Basilea, Calidi, Clearside, Curevac, Exelixis, Futuregen, Gracell, HDT, HLS, Invenra, Mannkind, Medivir, Moderna, Oncotelic, Oxurion, Pfizer, Quratis, Tetralogic, United.

Clinical data in 2021 has risen by about 9.2% in comparison with the same timeframe in 2020. As of mid-August, BioWorld has tracked a total of 2,400 entries of clinical data, which is up from the 2,197 entries last year. The gap has decreased from about 26% in mid-April, suggesting a steady slowdown in activity.

The CDC’s Advisory Committee on Immunization Practices (ACIP) deliberated the matter of third COVID-19 shots, with panel members voting whether to recommend “additional doses of mRNA COVID-19 vaccines as part of a primary [two-shot] series” in certain immunocompromised patients. A work group set up by ACIP decided previously that the desirable consequences outweighed undesirable ones in such a population.

Regulatory snapshots, including global drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Aprea, Biontech, Cytodyn, Immune-Onc, Ipsen, Jazz, Moderna, Novatek, Pfizer, Rigel.

Biopharma happenings, including deals and partnerships, grants, preclinical data and other news in brief: Advanced Chemotherapy, Ampio, Bexson, Cytocom, Fusion, Moderna, Mustang, Nyrada, RDIF, Sen-Jam, Theratechnologies.